Yann Echelard Tg Therapeutics, Inc. (TGTX) insider trading activity

Yann Echelard is Director of TG THERAPEUTICS, INC.. Currently has a direct ownership of 228,816 shares of TGTX, which is worth approximately $6.21 Million. The most recent transaction as insider was on Jun 13, 2025, when has been sold 10,000 shares (Common Stock) at a price of $36.94 per share, resulting in proceeds of $369,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 229K

2.11% 3M change

6.26% 12M change

Total Value Held $6.21 Million

Yann Echelard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 13 2025	SELL Open market or private sale	$369,400 $36.94 p/Share	10,000 Reduced 4.19%	228,816 Common Stock
Jun 12 2025	BUY Grant, award, or other acquisition	-	14,718 Added 5.81%	238,816 Common Stock
Nov 05 2024	SELL Open market or private sale	$489,600 $24.48 p/Share	20,000 Reduced 8.19%	224,098 Common Stock
Jun 19 2024	BUY Grant, award, or other acquisition	-	22,250 Added 8.35%	244,098 Common Stock
Sep 28 2023	BUY Grant, award, or other acquisition	-	20,000 Added 8.27%	221,848 Common Stock
Jan 06 2023	BUY Open market or private purchase	$95,760 $10.64 p/Share	9,000 Added 4.27%	201,848 Common Stock
Jul 20 2022	BUY Grant, award, or other acquisition	-	43,732 Added 18.49%	192,848 Common Stock
Jun 18 2021	BUY Grant, award, or other acquisition	-	20,000 Added 11.83%	149,116 Common Stock
Dec 10 2020	SELL Open market or private sale	$1,201,500 $40.05 p/Share	30,000 Reduced 18.85%	129,116 Common Stock

Yann Echelard

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TGTX shares.

Notify only if

Value

Insider Trading

Get notified when an Tg Therapeutics, Inc. insider buys or sells TGTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to TG THERAPEUTICS, INC.

Track Activities on TGTX

Account